Health and Life Sciences
A collection of law firm publications and PLC resources discussing issues relevant to health and life sciences. To view the full suite of PLC Law Department resources across 18 practice areas, simply visit our homepage.
8
resources
These resources are maintained, meaning that we monitor developments on a regular
basis and update them as soon as possible.
| 1 | Acquiring Pharmaceutical or Medical Device Manufacturers This Note explores selected legal and compliance issues for acquirors to focus on when pursuing an M&A transaction involving a target that is a manufacturer of pharmaceuticals or medical devices. In particular, this Note reviews the preliminary goals of effective due diligence, provides guidance on key areas of the investigation and highlights some of the strategies acquirors can use to mitigate risk in these deals. | Practice notes | Maintained |
| 2 | Are you looking for EU law content on this topic? A practice note explaining where to find EU law content from a topic page. | Practice notes | Maintained |
| 3 | Clinical trials on medicinal products for human use: legislation ... A practice note charting developments relating to the European Commission proposal for a Regulation on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Clinical Trials Directive) in chronological order. | Practice notes | Maintained |
| 4 | HIPAA Privacy Rule This Practice Note describes the requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) for protecting the privacy of personal health information. It includes a description of the entities and types of health information covered by the Privacy Rule, an overview of individual privacy rights and a discussion of the permitted and prohibited uses and disclosures of health information. | Practice notes | Maintained |
| 5 | HIPAA Security Rule This Note provides an overview of the requirements under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) for protecting the security of electronic protected health information (ePHI). It discusses the types of entities required to comply, the general requirements, guiding principles and related organizational and document requirements. This resource is in the process of being updated for final HIPAA regulations issued in January 2013. | Practice notes | Maintained |
| 6 | Pharmaceuticals Industry Guide: 2013 This Note provides a comprehensive overview of the US pharmaceutical industry. It includes a discussion of the main sectors and products, the characteristics of the market, and how it is regulated. It also analyzes the industry's risk factors, the types of legal relationships created, general tax and finance issues, mergers and acquisition considerations and typical strategic alliances. | Practice notes | Maintained |
| 7 | Using Option Structures to Reduce Buyer Risk in ... This Practice Note discusses some key issues to consider when structuring and negotiating an option to acquire a pharmaceutical company, such as purchase price, duration of the option, events triggering the option, the relevant product's development plan and antitrust and accounting implications. | Practice notes | Maintained |
| 8 | What's Market: M&A Agreements in the Healthcare Industry A discussion of key provisions in M&A agreements in the healthcare industry in private acquisitions and public mergers. This Note includes links to recent deals summarized in PLC What's Market and will be updated quarterly. | Practice notes | 31-Mar-2013 |